Nasogastric Tube Market 

The nasogastric tube market was valued for $401.95 million in 2023 and is estimated to reach $693.09 million by 2035, exhibiting a CAGR of 4.6% from 2024 to 2035.

Nasogastric tubes (NG tubes) are essential medical devices used to deliver nutrients, medications, and fluids directly into the stomach or remove gastric contents for diagnostic or therapeutic purposes. These flexible, hollow tubes are inserted through the nasal passage into the stomach and are indispensable in managing patients with cancer, gastrointestinal disorders, or requiring gastric decompression.

The nasogastric tube market growth is driven by surge in demand for rise in incidence of chronic diseases such as cancer, neurological disorders, and gastrointestinal disorders and technological advancements in nasogastric tubes. These conditions frequently necessitate enteral feeding due to complications that prevent adequate oral intake. For instance, according to the U.S. Department of Health & Human Services every 40 seconds, someone in the U.S. has a stroke and every year, more than 795,000 people in the U.S. have a stroke which is a leading cause of serious long-term disability. Thus, such conditions increase the adoption of nasogastric tubes.

Further, for instance, patients undergoing chemotherapy or radiation therapy for cancer often experience severe nausea and mucositis, making oral feeding challenging. Similarly, individuals with diabetes may suffer from gastroparesis, a condition that delays stomach emptying, requiring alternative nutritional support methods. Thus, growth in prevalence of chronic diseases directly correlates with increased demand for nasogastric tubes.

Furthermore, the market is additionally supported by the growing number of elderly people worldwide, who are more likely to experience chronic illnesses and eating challenges. Adoption has also been encouraged by developments in tube materials, such as silicone and polyurethane, which enhance patient comfort and lessen discomfort. Because NG tubes are minimally intrusive, hospitals and home healthcare services have been using them more and more, which has led to market expansion.

Moreover, an important contributing aspect has also been the increased emphasis on nutritional support in critical care environments. NG tubes offer a dependable and effective way to precisely enteral feed patients recovering from surgeries or suffering from serious illnesses. Additionally, tubes with anti-clogging designs and radiopaque markings for precise positioning have been developed, improving their safety and effectiveness and leading to broader acceptance. Another significant driver is the increasing utilization of NG tubes in pediatrics and neonatal care. Premature and critically ill infants often depend on these devices for feeding and medication administration. This segment’s growth is fueled by improvements in neonatal care facilities and a better understanding of infant nutrition.

Further, nasogastric tubes have shortcomings, including the potential for esophageal and nasal irritation, patient discomfort, and problems such aspiration pneumonia from improper implantation. Their use may be restricted by these problems, especially for long-term applications. In addition, the requirement for qualified medical personnel to guarantee correct insertion and upkeep raises operating expenses, which could be an obstacle in environments with limited resources.

The nasogastric tube market holds significant potential with the rising adoption of home healthcare services, particularly in developed regions. The shift towards portable and user-friendly NG tubes, combined with telemedicine integration for remote monitoring, presents an opportunity to expand access and convenience. Emerging markets in Asia-Pacific and Latin America, with growing healthcare infrastructure and awareness, also offer untapped potential for manufacturers.

The nasogastric tube market is segmented into type, application, end user, and region. By type, it is further categorized into levin tube, Salem sump tube, and others. By application, the market is fragmented into neurological disorders, cancer, and others. By end user, the market is segregated into hospitals, home care, and others.

Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Major key players that operate in the global nasogastric tube market are Becton, Dickinson and Company, QMD (Qure Medical Devices), Angiplast Pvt. Ltd., Securmed, Vygon, Cardinal Health, Poly Medicure Limited, Guangdong Baihe Medical Technology Co., Ltd., Sterimed Group, and Avanos Medical, Inc.The research methodology of the global market involves extensive primary and secondary research. Primary research includes about over 12 hours of interviews and discussion with a wide range of stakeholders, including upstream and downstream participants. The primary research typically is the bulk of our research efforts; however, coherently supported by extensive secondary research. Researchers have reviewed over 6,765 product literatures, industry releases, annual reports, and other such documents of key industry participants to obtain better market understanding and gain competitive intelligence. In addition, authentic industry journals, trade associations' releases,and government websites have also been reviewed for generating high-value industry insights. Show more